Peer-reviewedCC BYFrontiers in pharmacology
Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
- 1Medical School, Nantong University , , ,
Related
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
- Dose-dependent efficacy and renal safety of pemafibrate versus fenofibrate in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and hypertriglyceridemia: a multicenter randomized controlled, open label trial
- Efficacy and safety of imeglimin hydrochloride for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: Single-center, single-arm phase 2 (IMELD study).
- Comparative Efficacy and Safety of Saroglitazar and Dapagliflozin on Hepatic Steatosis and Glycemic Control in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A 25-Week Prospective Multicenter Comparative Cohort Study.
- Efficacy of Melatonin in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
BibTeX
@article{xie2026efficacy,
title = {{Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis}},
author = {Zhenghong Xie and Tianxing Chen},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13657923},
note = {CC BY},
}
RIS
TY - JOUR
TI - Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
AU - Zhenghong Xie
AU - Tianxing Chen
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13657923
SN - 1663-9812
ER -